Troutman Gregory S, Genuardi Michael V
Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA.
Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
J Clin Med. 2022 May 4;11(9):2575. doi: 10.3390/jcm11092575.
Survival after implant of a left ventricular assist device (LVAD) continues to improve for patients with end-stage heart failure. Meanwhile, more patients are implanted with a destination therapy, rather than bridge-to-transplant, indication, meaning the population of patients living long-term on LVADs will continue to grow. Non-LVAD healthcare providers will encounter such patients in their scope of practice, and familiarity and comfort with the physiology and operation of these devices and common problems is essential. This review article describes the history, development, and operation of the modern LVAD. Common LVAD-related complications such as bleeding, infection, stroke, and right heart failure are reviewed and an approach to the patient with an LVAD is suggested. Nominal operating parameters and device response to various physiologic conditions, including hypo- and hypervolemia, hypertension, and device failure, are reviewed.
对于终末期心力衰竭患者,植入左心室辅助装置(LVAD)后的生存率持续提高。与此同时,越来越多的患者接受目标治疗植入,而非桥接移植植入,这意味着长期使用LVAD的患者群体将持续增长。非LVAD医疗服务提供者在其执业范围内会遇到此类患者,熟悉并掌握这些装置的生理学、操作及常见问题至关重要。本文综述描述了现代LVAD的历史、发展及操作。对LVAD相关的常见并发症,如出血、感染、中风和右心衰竭进行了综述,并提出了针对LVAD患者的处理方法。还综述了名义操作参数以及装置在各种生理状况下的反应,包括血容量不足和过多、高血压及装置故障。